Mucopolysaccharidosis I (MPS I) Registry
Key facts
- Who runs it
- Genzyme, a Sanofi Company
- Where
- Ann Arbor, Aurora, Baltimore, Boston, Charlottesville, Chicago, Cincinnati, Columbus, Dallas, Decatur, Durham, Gainesville, Greenville, Hackensack, Indianapolis, Iowa City, Las Vegas, Little Rock, Los Angeles, Louisville, Manhasset, Miami, Milwaukee, Minneapolis, New Brunswick, New Haven, New York, Norfolk, Oakland, Omaha, Orange, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Sacramento, Salt Lake City, San Diego, San Francisco, Seattle, Springfield, St Louis, Syracuse, Tampa, and Washington D.C., United StatesSee the 53 sitesAlso in 36 other countries, 88 sites
- Trial code
- NCT00144794
- U1111-1294-8266
- Status
- Completed
- People taking part
- 1,406 people enrolled
- Started
- 20 Nov 2003
- Ended
- 31 Dec 2024
- Type of study
- Observational
- Record updated
- 27 February 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- All patients with a confirmed diagnosis of MPS I are eligible for inclusion. Confirmed diagnosis is defined as: A. documented biochemical evidence of a deficiency in alpha (a)-L-iduronidase enzyme activity and/or B. mutation(s) in the gene coding for a-L-iduronidase, or measurable clinical signs and symptoms of MPS I
- For all patients there should be a completed patient authorization form
Who cannot take part
- No exclusion criteria for participation in the MPS I Registry. NOTE: Registry participation does not exclude participation in other clinical studies
Where in United States
Also in 36 other countries, 88 sites
- University Of Michigan Pediatrics- Site Number : 840107Ann Arbor, United States
- Children's Hospital Colorado - Aurora- Site Number : 840069Aurora, United States
- University Of Colorado At Denver Genetics- Site Number : 840068Aurora, United States
- Baltimore, MarylandHospital not named in the registry
- Boston Children's Hospital - PIN- Site Number : 840093Boston, United States
- Massachusetts General Hospital-Genetics- Site Number : 840062Boston, United States
- University Of Virginia School Of Medicine-Pediatrics- Site Number : 840078Charlottesville, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago- Site Number : 840011Chicago, United States
- Rush University Medical Center Genetics- Site Number : 840079Chicago, United States
- Cincinnati Children's Hospital-Genetics- Site Number : 840041Cincinnati, United States
- Nationwide Children's Hospital- Site Number : 840091Columbus, United States
- Baylor Institute of Metabolic Disease- Site Number : 840058Dallas, United States
- Emory University School Of Medicine- Human Genetics- Site Number : 840060Decatur, United States
- Duke University Medical Center Genetics Dept- Site Number : 840037Durham, United States
- University Of Florida Dept Of Genetics- Site Number : 840083Gainesville, United States
- Greenwood Genetic Center - Greenville- Site Number : 840055Greenville, United States
- Joseph M. Sanzari Children'S Hospital- Site Number : 840101Hackensack, United States
- Indianapolis University School Of Medicine- Site Number : 840027Indianapolis, United States
- University of Iowa- Site Number : 840032Iowa City, United States
- Children's Specialty Center - Las Vegas- Site Number : 840008Las Vegas, United States
- Arkansas Children's Hospital- Site Number : 840109Little Rock, United States
- Southern California Permanente Medical Group- Site Number : 840108Los Angeles, United States
- Usc Health Sciences Center Dept Of Genetics- Site Number : 840082Los Angeles, United States
- University of Louisville- Genetics- Site Number : 840030Louisville, United States
- Northwell Health - Site Number : 840102Manhasset, United States
- University Of Miami SOM- Site Number : 840006Miami, United States
- Children's Hospital of Wisconsin-Pediatrics- Site Number : 840054Milwaukee, United States
- University of Minnesota Medical Center Pediatrics- Site Number : 840076Minneapolis, United States
- Saint Peter's University Hospital - New Brunswick- Site Number : 840016New Brunswick, United States
- Yale University School of Medicine- Site Number : 840047New Haven, United States
- New York University School Of Medicine- Site Number : 840040New York, United States
- Children's Hospital of The King's Daughters- Site Number : 840072Norfolk, United States
- UCSF Benioff Children's Hospital - Oakland- Site Number : 840029Oakland, United States
- University of Nebraska Medical Center- Site Number : 840084Omaha, United States
- Children's Hospital of Orange County- Site Number : 840074Orange, United States
- Stanford Unviersity MC Dept of Genetics- Site Number : 840022Palo Alto, United States
- Children'S Hospital Of Philadelphia Hup Medical Genetics- Site Number : 840089Philadelphia, United States
- Children's Hospital of Philadelphia- Site Number : 840034Philadelphia, United States
- Phoenix Children's Hospital- Site Number : 840003Phoenix, United States
- University of Pittsburgh- Site Number : 840023Pittsburgh, United States
- Oregon Health & Science University (OHSU)- Site Number : 840080Portland, United States
- Rhode Island Hospital Genetics- Site Number : 840053Providence, United States
- Uc Davis Mind Institute- Site Number : 840010Sacramento, United States
- University of Utah Health Hospital- Site Number : 840092Salt Lake City, United States
- University of California at San Diego- Site Number : 840007San Diego, United States
- University of California at San Francisco- Site Number : 840051San Francisco, United States
- Seattle Children's Hospital- Site Number : 840028Seattle, United States
- University of Washington Medical Center- Site Number : 840059Seattle, United States
- Baystate Medical Center- Site Number : 840002Springfield, United States
- Washington University- Site Number : 840100St Louis, United States
- State University of New York- Site Number : 840052Syracuse, United States
- Tampa, FloridaHospital not named in the registry
- Children's National Medical Center - Washington- Site Number : 840067Washington D.C., United States
About the trial
What the trial wants to find out
The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients receiving enzyme replacement therapy, such as Aldurazyme (Recombinant Human Alpha-L-Iduronidase), or other treatment modalities.
Read full original descriptionShow less
The objectives of the Registry are:
* To evaluate the long-term effectiveness and safety of Aldurazyme® (laronidase) * To characterize and describe the MPS I population as a whole, including the variability, progression, and natural history of MPS I * To help the MPS I medical community with the development of recommendations for monitoring patients and reports on patient outcomes to optimize patient care
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 27 February 2026